共查询到20条相似文献,搜索用时 15 毫秒
1.
Granderath FA Kamolz T Schweiger UM Pasiut M Haas CF Wykypiel H Pointner R 《Surgical endoscopy》2002,16(5):753-757
Background: It is estimated that laparoscopic antireflux surgery has replaced the open approach in centers worldwide. Findings
show it to be an established treatment option for chronic gastroesophageal reflux disease with an excellent clinical outcome
and success rates between 85% and 95%. This prospective study aimed to evaluate surgical outcome and analysis of failure after
500 laparoscopic antireflux procedures followed up for as long as 5 years. Methods: Between September 1993 and May 2000, 500
laparoscopic antireflux procedures were performed in our surgical unit. In 345 patients, a laparoscopic "floppy" Nissen fundoplication
was performed, and in 155 patients, a Toupet fundoplication was carried out with standard mobilization of the upper part of
the gastric fundus and with division of the short gastric vessels. Preoperative and postoperative data including 24-h pH monitoring,
esophageal manometry, and analysis of failure were prospectively reviewed. Results: Conversion to open surgery was necessary
in two patients (0.4%). Morbidity was 7%, including 24 patients (4.8%) for whom a laparoscopic redoprocedure was necessary
because of failed primary intervention. There was no mortality. During a follow-up period of 3 months to 5 years, 24-h pH
monitoring and esophageal manometry showed normal values in 95% of the patients including patients who had undergone redosurgery.
Conclusion: The results of the current study demonstrate that laparoscopic antireflux surgery is feasible and effective, and
that it can be performed safely without mortality and with low morbidity, yielding good to excellent results over a follow-up
period up to 5 years. 相似文献
2.
Outcome of laparoscopic antireflux surgery in patients with nonerosive reflux disease 总被引:2,自引:0,他引:2
Tanja Bammer M.D. Mark Freeman M.D. Ali Shahriari M.D. Ronald A. Hinder M.D. Ph.D. F.A.C.G. Kenneth R. DeVault M.D. F.A.C.G. Sami R. Achem M.D. F.A.C.P. F.A.C.G. 《Journal of gastrointestinal surgery》2002,6(5):730-737
As many as 50% of patients with gastroesophageal reflux disease (GERD) have no endoscopic evidence of esophagitis (EGD negative).
Laparoscopic antireflux surgery (LARS) provides effective symptomatic and endoscopic healing in patients with erosive GERD
(EGD positive). The surgical outcome of patients undergoing LARS for EGD-negative GERD has not received wide attention. The
objective of this study was to compare surgical outcomes between EGD-negative and EGD-positive patients. During the period
from June 1996 to September 1998, all patients undergoing LARS for persistent GERD symptoms despite medical therapy, who were
EGD-negative, were invited to respond to a questionnaire regarding their clinical status before and after LARS. To perform
a comparative analysis, the same questions were posed to a randomly selected equal number of EGD-positive patients who underwent
surgery during the same study period. LARS was performed in 255 patients during the study period; 59 patients (23%) had EGD-negative
GERD, and 148 (58%) were EGD-positive. Forty-eight patients (19%) did not meet the entry criteria and were excluded from analysis.
LARS provided effective symptomatic relief in patients with EGD-negative and EGD-positive GERD. There were no significant
differences in patient satisfaction or symptom improvement between the two groups (P = 0.82). The surgical outcome of EGD-negative patients is similar to the outcome for patients with erosive esophagitis. LARS
is a valuable treatment option for patients with persistent GERD symptoms regardless of the endoscopic appearance of the esophageal
mucosa.
Presented in abstract form at the Annual Meeting of the American Gastroenterology Association, Orlando, Florida, May 15, 1999. 相似文献
3.
Laparoscopic antireflux surgery with routine Mesh-Hiatoplasty in the treatment of gastroesophageal reflux disease 总被引:7,自引:0,他引:7
Frank A. Granderath M.D. Ursula M. Schweiger M.D. Thomas Kamolz M.D. Martin Pasiut M.D. Christoph F. Haas M.D. Rudolph Pointner M.D. 《Journal of gastrointestinal surgery》2002,6(3):347-353
One of the most frequent complications after laparoscopic antireflux surgery is intrathoracic migration of the wrap ("slipped"
Nissen fundoplication). The most common reasons for this are inadequate closure of the crura or disruption of the crural closure.
The aim of this prospective study was to evaluate surgical outcomes in patients who underwent laparoscopic antireflux surgery
with simple nonabsorbable polypropylene sutures for hiatal closure in comparison to patients who underwent routine mesh-hiatoplasty.
Between 1993 and 1998, a group of 361 patients underwent primary laparoscopic Nissen or Toupet fundoplication with the use
of simple nonabsorbable polypropylene sutures for hiatal closure. Since December 1998, in all patients (n = 170) who underwent
laparoscopic antireflux surgery, a 1 × 3 cm polypropylene mesh was placed on the crura behind the esophagus to reinforce them.
Functional outcome, symptoms of gastroesophageal reflux disease, and postoperative complications such as recurrent hiatal
hernia with or without intrathoracic migration of the wrap have been used for assessment of outcomes. In the initial series
of 361 patients, postoperative herniation of the wrap occurred in 22 patients (6.1%). Of these 22 patients, 17 of them (4.7%)
had to undergo laparoscopic redo surgery. The remaining five patients were free of symptoms. In comparison to these results,
in a second group of 170 patients there was only one (0.6%) who had postoperative herniation of the wrap into the chest. There
have been no significant differences in objective data such as DeMeester scores or lower esophageal sphincter pressure between
the two groups. Postoperative dysphagia was increased during the early period after surgery in patients undergoing mesh-hiatoplasty
but resolved without any further treatment within the first year after laparoscopic antireflux surgery. We concluded that
routine hiatoplasty with the use of a polypropylene mesh is effective in preventing postoperative herniation of the wrap and
leads to a significantly better surgical outcome than closure of the hiatal crura with simple sutures, without any additional
long-term side effects.
Presented at the Forty-Second Annual Meeting of The Society for Surgery of the Alimentary Tract, Atlanta, Georgia, May 20–23,
2001 (poster presentation); and the Ninth International Congress of the European Association for Endoscopic Surgery, Maastricht,
The Netherlands, June 15, 2001; and published as an abstract in Gastroenterology 120:A 480, 2001. 相似文献
4.
BACKGROUND: Both gastroesophageal reflux and paraesophageal hernias are more common in the elderly, but often these patients are not referred for surgery because of their age. In this study we determined the outcome for laparoscopic antireflux surgery in patients aged 70 years or older, in whom either symptoms of gastroesophageal reflux or a large paraesophageal hernia was the indication for surgery. METHOD: From a prospectively maintained clinical database of patients undergoing laparoscopic antireflux surgery, all patients aged 70 years or older were identified and their outcome was determined. RESULTS: Two hundred ten patients were identified. In 129 a large paraesophageal hiatus hernia was the primary indication for surgery, and in 81 patients the indication was reflux. Mean operation time was significantly longer in patients undergoing surgery for a large hiatus hernia (109 vs. 72 min), and conversion to open surgery was required more often (11.6% vs. 4.4%), compared to patients with reflux alone. Follow-up information was available for 95% of patients. Postoperative symptom scores for heartburn and dysphagia improved significantly and patients' satisfaction with surgery was high. CONCLUSION: Laparoscopic antireflux surgery in patients aged 70 years or older has a satisfactory clinical outcome. Elderly patients should not be refused laparoscopic antireflux surgery only because of their age. 相似文献
5.
目的:探讨腹腔镜抗反流手术治疗胃食管反流病的疗效及手术指征选择。方法:总结2000年至2013年收治的185例胃食管反流病病人的临床资料和术后近期远期结果(生活质量、病人满意率、抗反流手术相关并发症及复发),分析腹腔镜抗反流手术的安全性和有效性。结果:185例病人均顺利施行腹腔镜抗反流手术(食管裂孔修补+胃底折叠),手术用时50~200 min,术中失血10~100 mL,无中转开腹和手术死亡病例。20例病人发生围手术期并发症,经针对性处理后痊愈;术后并发慢性吞咽困难16例,多为轻、中度;163例GERD病人术后日常生活质量改善明显,手术满意率达88.1%;166例病人术前胃食管反流症状典型,术后152例症状明显改善(91.6%),14例无缓解。随访见8例术后复发,其中2例合并食管裂孔疝复发。结论:腹腔镜手术治疗胃食管反流病安全可行、疗效可靠,但术前应严格把握手术适应证。 相似文献
6.
Effects of manometrically discovered nonspecific motility disorders of the esophagus on the outcomes of antireflux surgery 总被引:1,自引:0,他引:1
Nonspecific motility disorders (NMDs) of the esophagus are common manometric findings in patients evaluated for gastroesophageal
reflux disease (GERD). However, it is unclear how these disorders affect the outcomes of antireflux surgery. The purpose of
this study was to assess symptomatic outcomes of patients with and without NMDs undergoing surgical treatment for GERD. A
prospectively gathered database of all patients undergoing antireflux surgery was retrospectively reviewed for preoperative
symptoms, symptom severity using the GERD-HRQL (best score 0, worst score 50), esophageal manometry measurements, presence
of NMD, type of operation, any transient or permanent postoperative dysphagia, severity of postoperative dysphagia (best score
0, worst score 5), and postoperative symptom severity. A total of 239 patients were studied; 24% had a NMD identified by preoperative
esophageal manometry, and 17% of this +NMD group had preoperative dysphagia or atypical chest/epigastric pain compared to
28% of those without a NMD (-NMD group) (P=NS). Preoperative symptom scores were +NMD 33 vs. -NMD 27 (P=0.01). Postoperative symptom scores were +NMD 5 vs. -NMD 3 (P=NS). There were no differences in preoperative or postoperative dysphagia scores. Transient postoperative dysphagia was 15.8%
in the +NMD group vs. 16.4% in the -NMD group (P=NS). Postoperative dilation was 0% in the +NMD group vs. 2% in the -NMD group (P=NS). Manometrically discovered NMDs do not appear to affect preoperative symptoms or symptomatic outcomes of patients surgically
treated for GERD. These findings my reflect the severity of GERD and may improve with antireflux surgery. 相似文献
7.
Frank A. Granderath M.D. Thomas Kamolz Ph.D. Ursula M. Schweiger M.D. Rudolph Pointner M.D. 《Journal of gastrointestinal surgery》2002,6(6):812-818
Quality of life and patient satisfaction have been shown to be important factors in evaluating outcome of laparoscopic antireflux
surgery (LARS). The aim of this study was to evaluate data pertaining to quality of life, patient satisfaction, and changes
in symptoms in patients who underwent laparoscopic redo surgery after primary failed open or laparoscopic antireflux surgery
3 to 5 years postoperatively. Between March 1995 and June 1998, a total of 27 patients whose mean age was 57 years (range
35 to 78 years) Underwent laparoscopic refundoplication for primary failed open or laparoscopic antireflux surgery. Quality
of life was evaluated by means of the Gastrointestinal Quality of Life Index (GIQLI). Additionally, patient satisfaction and
symptomatic outcome were evaluted using a standardized questionnaire. Three to 5 years after laparoscopic refundoplication,
patients rated their quality of life (GIQLI) in an overall score of 113.4 points. Twenty-five patients (92.6%) rated their
satisfaction with the redo procedure as very good and would undergo surgery again, if necessary. These patients were no longer
taking any antireflux medication at follow-up. Two patients (7.4%) reported rare episodes of heartburn, which were managed
successfully with proton pump inhibitors on demand, and four patients (14.8%) reported some episodes of regurgitation but
with no decrease in quality of life. Seven patients (25.9%) suffer from mild-to-moderate dysphagia 5 years postoperatively,
and 12 patients (44.4%) report having occasional chest pain but no other symptoms of gastroesophageal reflux disease. Nine
of these patients suffer from concomitant cardiopulmonary disease. Laparoscopic refundoplication after primary failed antireflux
surgery results in a high degree of patient satisfaction and significant improvement in quality of life with a good symptomatic
outcome for a follow-up period of 3 to 5 years after surgery.
Presented at the Forty-Third Annual Meeting of The Society for Surgery of the Alimentary Tract, San Francisco, California,
May 19–22, 2002 (poster presentation). 相似文献
8.
Clinical outcome of Laparoscopic antireflux surgery for patients with irritable bowel syndrome 总被引:2,自引:0,他引:2
Raftopoulos Y Papasavas P Landreneau R Hayetian F Santucci T Gagné D Caushaj P Keenan R 《Surgical endoscopy》2004,18(4):655-659
Background The prevalence of irritable bowel syndrome (IBS) is higher among subjects with gastroesophageal reflux disease (GERD). This study aimed to assess the effect of IBS on the postoperative outcome of antireflux surgery.Methods For this study, 102 patients who underwent laparoscopic fundoplication were screened preoperatively for IBS with the Rome II criteria. There were 32 patients in the IBS group and 70 patients in the non-IBS group. Most of the patients (97%) (31 of 32 IBS and 68 of 70 non-IBS patients) had both pre- and postoperative IBS evaluation. A visual analog GERD-specific scoring scale was used to evaluate GERD symptoms prospectively.Results In both groups, GERD symptom scores were statistically improved postoperatively. Of the 31 IBS patients 25 (80.6%) showed a reduction in their symptoms below the Rome II criteria for IBS diagnosis postoperatively.Conclusion Irritable bowel syndrome does not have a negative effect on the outcome of laparoscopic antireflux surgery. Surgical correction of GERD may improve the severity of irritable bowel symptoms. 相似文献
9.
J. Esteban Varela Marcelo W. Hinojosa Ninh T. Nguyen 《American journal of surgery》2008,196(6):989-993
Background
Open and laparoscopic antireflux surgeries are standard for the treatment of gastroesophageal reflux disease (GERD). The in-hospital outcomes of laparoscopic and open antireflux procedures were analyzed and compared at US academic medical centers.Methods
Using International Classification of Diseases, Ninth Revision, Clinical Modification codes for 5,737 patients with GERD that underwent open (n = 1,377) or laparoscopic (n = 4,360) antireflux surgery were identified from the University Health-System Consortium Database over a 3-year period (2004-2007). Demographic and outcome data measured included length of stay, overall complications, in-hospital mortality, observed-to-expected mortality ratio (risk-adjusted mortality), and hospital costs.Results
Laparoscopic antireflux procedures offered significantly lower mean length of stay, in-hospital morbidity, and hospital costs. Both procedures had a low observed to expected in-hospital mortality. Open surgery was associated with significantly higher procedure-related and pulmonary complications.Conclusions
In the context of US academic centers, approximately three quarters of antireflux procedures are being performed using the laparoscopic approach. These data suggest that laparoscopy has improved in-hospital outcomes when compared with open surgery and is preferred for the surgical treatment of GERD. 相似文献10.
Psychiatric disorders affect outcomes of antireflux operations for gastroesophageal reflux disease 总被引:1,自引:0,他引:1
apd: 20 October 2000 相似文献
11.
Ketan M. Desai M.D. Margaret M. Frisella R.N. Nathaniel J. Soper M.D. 《Journal of gastrointestinal surgery》2003,7(1):44-52
A wide spectrum of endoscopic findings exists in patients with gastroesophageal reflux disease (GERD). This study compared
clinical outcomes after laparoscopic antireflux surgery (LARS) in patients who had GERD with and without preoperative endoscopic
esophagitis. From 1992 to 2001, a total of 414 patients who underwent LARS with 6 months or more of follow-up were prospectively
entered into a database. Among these patients, 84 (20%) had no endoscopic evidence of esophagitis on preoperative endoscopy
(group 1), whereas 330 (80%) did have esophagitis (group 2). Perioperative outcomes, GERD symptom relief, and the use of acid-reducing
medication were assessed. Preoperative DeMeester scores in groups 1 and 2 were 44 ± 29 and 61 ± 62 (P < 0.05) and mean esophageal
peristaltic amplitude was 86 ± 32 mm Hg vs. 60 ± 42 mm Hg, respectively (P < 0.05). Although procedure time was significantly
shorter in group 1, other perioperative outcomes were similar. At postoperative follow-up, the use of proton pump inhibitors
was reduced in both groups (86% to ≤14%). With the exception of postoperative dysphagia, there was no difference in GERD symptom
relief between groups 1 and 2. The presence or absence of preoperative esophagitis has minimal effect on favorable symptomatic
outcomes after LARS. Thus LARS is an effective treatment option for patients, irrespective of endoscopic evidence of esophagitis,
leading to excellent symptom relief and a marked reduction in the use of proton pump inhibitors.
Presented at the Forty-Third Annual Meeting of The Society for Surgery of the Alimentary Tract, San Francisco, California,
May 19–22, 2002 (oral presentation).
Supported by the Washington University Institute for Minimally Invasive Surgery. 相似文献
12.
Background The purpose of our study was to develop a quality-of-life (QoL) questionnaire for patients with gastroesophageal reflux disease (GERD) who have undergone laparoscopic fundoplication. This questionnaire was developed to be more comprehensive than existing measures.Methods Between 1994 and 2002, 252 patients underwent laparoscopic fundoplication for GERD in the 1st Department of Surgery, Semmelweis University. We undertook a retrospective analysis: each of 252 operated patients was given a questionnaire and was requested to complete it and return it in an enclosed envelope. A total of 116 patients returned completed questionnaires. The patients included 55 men and 61 women, with a mean age of 46 years (range 14–77). These patients were used in the psychometric evaluation. The questionnaire consisted of 50 questions (including the Visick score, EORTC-QLQ-C30, and a modified GERD-HRQL).Results Internal consistency reliability was high (alpha value overall, 0.95, range, 0.74–0.96). Using convergent and divergent validity, construct validity was evaluated by examining Pearson correlation coefficients between items and scales. Construct validity was demonstrated based on observed correlations. Known groups validity was upheld because patients who experienced more symptoms and patients who has higher Visick scores reported worse QoL than those with less symptoms or lower Visick scores.Conclusions Our questionnaire is a short and user-friendly instrument with excellent psychometric properties. It has been found to be valid and reliable. 相似文献
13.
Winslow ER Clouse RE Desai KM Frisella P Gunsberger T Soper NJ Klingensmith ME 《Surgical endoscopy》2003,17(5):738-745
Background: The clinical outcomes of laparoscopic antireflux surgery (LARS) in patients with the spectrum of nonspecific spastic esophageal motor disorders (NSSDs) are not known. Methods: From a prospective database of patients undergoing LARS between 1997 and 2000, those with preoperative manometry at our institution and follow-up at 6 months were identified. Results: Of the 121 patients, 35 had NSSDs. There were no differences in symptoms between groups preoperatively, but in the immediate postoperative period NSSD patients had more symptoms than nonspastic patients. At 18-month mean follow-up, NSSD patients reported significantly more heartburn (22% vs 7%), waterbrash (14% vs 4%), and medication usage (17% vs 5%) than nonspastic patients (p < 0.05 for each). Despite this difference, nearly all patients reported subjective improvement postoperatively, and the degree of improvement was similar between groups. Conclusions: Patients with NSSDs are more likely to have esophageal symptoms following LARS than subjects without these abnormalities. However, these patients still experience significant improvement in preoperative symptoms.
Presented at the 8th World Congress Society of American Gastrointestinal Endoscopic Surgeons (SAGES). New York, NY, USA, March 2002 相似文献
14.
Wilkerson PM Stratford J Jones L Sohanpal J Booth MI Dehn TC 《Surgical endoscopy》2005,19(9):1272-1277
Background We aimed to determine if a poor response to proton pump inhibitors (PPIs) can predict a poor outcome following laparoscopic
antireflux surgery (LARS) in our surgically treated population.
Methods A total of 324 patients undergoing LARS were included in this study. Following standardized assessment, patients recorded
the efficacy of their medication on visual analogue scales. Pre- and postoperative symptom scores were recorded, with outcomes
measured by modified Visick scores.
Results There were 233 good responders (>50% relief) and 91 poor responders (<49% relief). Both groups demonstrated a significant
decline in postoperative symptom scores. Ninety-four percent of good responders had an excellent or good outcome, compared
to 87% of poor responders. Twenty-seven patients reported a fair or poor outcome, despite improved postoperative symptom scores.
Fifteen of these patients reported continuing heartburn; five had positive pH tests.
Conclusion Our results do not support the assumption that a poor response to PPIs equates to a poor outcome after LARS. 相似文献
15.
Background Currently, evaluation of patient satisfaction and quality-of-life data to estimate the outcome of laparoscopic antireflux
surgery is an important issue. This study aimed first to report the midterm results for the surgical management of gastroesophageal
reflux disease (GERD) by laparoscopic fundoplication and to evaluate surgical outcome, including quality of life and patient
satisfaction. The second aim was to determine whether preoperative quality-of-life measurement can predict which patients
will be satisfied with antireflux surgery.
Methods The current prospective study evaluated the outcome of the quality-of-life data for 41 patients (13 men and 28 women) who
underwent laparoscopic fundoplication in the author’s department of surgery between 1 January 2002 and 31 May 2003. The mean
age of the patients was 41 years. Quality of life was measured by using a new quality-of-life instrument (QOLARS) developed
and validated by the author’s study group. The patients completed the QOLARS questionnaire before surgery, then 6 weeks, 1
year, and 3 years after surgery.
Results Before surgery, all the patients had a poor quality of life. The general quality-of-life and heartburn scores improved significantly
within 6 weeks after surgery and showed further improvement by the end of the first postoperative year, then remained stable
3 years after surgery. The patients who became completely free of reflux-related symptoms were divided into two groups according
to their satisfaction with the operative result. The patients dissatisfied with surgery had significantly worse median preoparative
scores in four domians (physical functioning, emotional functioning, sleep disturbance, constipation) than the patients satisfied
with the procedure.
Conclusions The findings show that QOLARS is a sensitive tool for assessing surgical outcome after laparoscopic antireflux surgery. The
quality-of-life response closely follows the clinical outcome of surgical treatment, reflecting its side effects as well.
This study suggests that a generic quality-of-life scale can preoperatively identify patients with GERD who are likely to
be dissatisfied with antireflux surgery. 相似文献
16.
Ruxandra Ciovica M.D. Michael Gadenstätter M.D. M.Sc. Anton Klingler Ph.D. Wolfgang Lechner M.D. Otto Riedl M.D. Gerhard P. Schwab M.D. M.B.A. 《Journal of gastrointestinal surgery》2006,10(7):934-939
Medical and surgical treatments are able to improve symptoms in patients with gastroesophageal reflux disease (GERD). The
aim of this study was to evaluate the outcome in GERD patients without therapy, under continuous medical treatment, and after
laparoscopic antireflux surgery. Five hundred seventy-nine consecutive patients underwent medical or surgical treatment for
GERD-induced symptoms. Patients were studied in detail before and after treatment by means of a symptom questionnaire, endoscopy,
esophageal manometry, 24-hour esophageal pH monitoring, and a barium esophagogram. In addition, quality of life was measured
by the means of the Gastrointestinal Quality of Life Index (GIQLI) and the Health-Related Quality of Life (HRQL) questionnaire.
Surgery was indicated and performed in 351 patients with persistent or recurrent GERD symptoms and/or complications, and in
patients preferring surgery to medical treatment, despite the use of an adequate medication. The remaining 228 patients were
treated with proton pump inhibitors (PPI) in the standard dose, or if required, the double dose. The outcome was assessed
3 and 12 months after treatment. While symptoms and quality of life were highly impaired in GERD patients without therapy
compared with normal people, a significant improvement was obtained by PPI therapy. Following surgery, quality of life was
normalized in all subsections and was significantly higher compared with the medically treated group. These results stayed
constant in short-term and intermediate follow-up. Medical and surgical therapies are both able to improve symptoms and quality
of life in GERD patients. Nevertheless, the outcome is significantly better following surgery. It can be suggested that surgical
treatment may be the more successful therapy in the long-term.
Presented at the Forty-Sixth Annual Meeting of The Society for Surgery of the Alimentary Tract, Chicago, Illinois, May 14–19,
2005 (poster presentation). 相似文献
17.
Olivier Brehant M.D. Patrick Pessaux M.D. Jean-Pierre Arnaud M.D. Delattre Jean-François M.D. Christian Meyer M.D. Jacques Baulieux M.D. Henri Mosnier M.D. 《Journal of gastrointestinal surgery》2006,10(3):439-444
The aim of this retrospective study was to compare results and five-year surgical outcome of laparoscopic antireflux surgery
(LARS) in patients younger than 65 years and elderly patients aged 65 years or older. From January 1992 to December 1998,
2684 patients underwent LARS in 31 surgical units; 369 elderly patients (group 1) were compared with 2315 younger patients
(group 2). Elderly patients have a higher American Society of Anesthesiologists score (mean, 2.38 versus 1.98). The conversion
rate was higher in group 1 (10.2%, n = 38 versus 6.1%, n = 142), as was the morbidity rate (7.6% in group 1 versus 4.5% in
group 2). Mean hospital stay was longer for group 1 (7.6 ± 5.6 days versus 5.9 ± 2.8 days). Functional evaluation was excellent
in both groups (91-93%) at 3 months and 2 and 5 years. LARS in the elderly is a safe and efficient procedure. Good results
appear to be sustainable in the long term.
The study participants are listed at the end of the article. 相似文献
18.
Comparative results of endoluminal gastroplasty and laparoscopic antireflux surgery for the treatment of GERD 总被引:1,自引:0,他引:1
Background: Transoral endoluminal gastroplasty (EG) by the Bard Endocinch device is available for the treatment of gastroesophageal reflux disease (GERD). This study assessed the early (12 months) outcomes in patients undergoing EG performed by one gastroenterologist compared with another set of patients referred by the same gastroenterologist for laparoscopic antireflux surgery (LAS) at a foregut surgery center. Methods: From June 2000 to July 2002, 87 consecutive patients cared for by a single gastroenterologist were diagnosed with refractory GERD and underwent either EG (n = 47) or referral for LAS (n = 40). Preoperative evaluation included symptom assessment, pH studies, and motility studies. Outcomes were assessed by symptomatic improvement and dependence on anti-acid medications. Data analyzed by chi-square or Mann-Whitney tests are reported as mean ± SEM. Results: Preoperative symptom duration, Johnson-DeMeester (JD) score, % time pH < 4, and reflux episodes were statistically similar in both treatment groups. The follow-up times for EG and LAS groups were 7.3 ± 0.9 and 8 ± 0.4 months, respectively. Of EG patients, 94% were available for follow-up, and all LAS patients had follow-up data. Overall, 66% of patients were satisfied with EG as compared to 93% after LAS (p = 0.1). Postoperative PPI/motility agent use was 32% for EG and 13% for LAS (p = 0.03). Identifiable causes of EG failure were premature procedure termination due to hypoxia or bleeding (three patients), intractable vomiting (two patients), and delayed gastric emptying (five patients). Three EG patients subsequently had LAS within 6 months of the procedure. Conclusions: LAS offers greater reduction in medication use than EG, as well as more durable patient satisfaction. Benefits of EG may include short-term symptomatic improvement while considering definitive surgical management.
Presented at the annual meeting of the Society of American Gastrointestinal Surgery (SAGES), Los Angeles, CA, USA, 15 March 2003 相似文献
19.
Background: Antireflux surgery (ARS) is a well established treatment for GERD (gastroesophageal reflux disease). The present
study gives an overview of experience in Austria regarding the frequency of open and laparoscopic ARS and how Austrian departments
meet the requirements for surgery. Methods: A questionnaire was sent to 115 surgical departments in Austria to evaluate in
how many institutions antireflux surgery (open and/or laparoscopically) was performed since 1990, and which pre- and postoperative
tests were obligatory, optional, or not performed. Units were divided into specialized and nonspecialized. Results: The laparoscopic
approach has gained in importance by about 300% in the past 5 years in the few hospitals performing this procedure. Esophageal
manometry and 24-h pH monitoring were rarely done in nonspecialized units, despite the fact that GERD is mainly a functional
disorder of the esophagus and stomach. In contrast to the nonspecialized units, the specialized unit performed upper endoscopy,
esophageal manometry and 24-h esophageal pH monitoring as obligatory tests. Conclusions: ARS, both open and laparoscopic,
is not commonly performed in surgical departments in Austria but the frequency has significantly increased in recent years.
Laparoscopic ARS is a safe procedure in hospitals performing this frequently. Laparoscopic ARS should only be performed in
specialized units with significant experience in gastroesophageal diseases, where functional testing of the esophagus can
be done. 相似文献
20.
Ruxandra Ciovica Otto Riedl Christoph Neumayer Wolfgang Lechner Gerhard P. Schwab Michael Gadenstätter 《Surgical endoscopy》2009,23(9):1938-1946
Background Laparoscopic antireflux surgery (LARS) significantly improves symptoms of gastro-esophageal reflux disease (GERD) and quality
of life. Nevertheless, 14–62% of patients report using antisecretory medication after surgery, although only a tiny percentage
has proven recurrence of GERD. We sought to determine symptoms of GERD, quality of life, and use of medication before and
after LARS, and to compare our findings with those from previous studies.
Methods Five hundred fifty-three patients with GERD who underwent LARS were evaluated before and at 1 year after surgery. After surgery,
multidisciplinary follow-up care was provided for all patients by surgeons, psychologists, dieticians, and speech therapists.
Results Symptoms of GERD and quality of life improved significantly and only 4.2% of patients still required medication after surgery
[proton pump inhibitors (PPI) (98.4 vs. 2.2%; p < 0.01), prokinetics (9.6 vs. 1.1%; p < 0.01), and psychiatric medication (8 vs. 1.6%; p < 0.01)].
Conclusion LARS significantly reduced medication use at 1-year follow-up. However, these effects might be attributed, in part, to the
multidisciplinary follow-up care. Further studies are therefore required to investigate which patients may benefit from multidisciplinary
follow-up care and whether its selective application may reduce the need for medication after LARS. 相似文献